EU Gene Therapy Submissions, Approvals Expected To Pick Up In 2021

Coming year could feature first-time approvals in the EU for at least five gene therapies.

2021 Pink Sheet Perspectives - gene therapy
Biomarin, Krystal Biotech, Orchard Therapeutics expected to submit gene therapies in 2021 for EU review.

First-time approvals of gene therapies globally were relatively low in 2020, but activity of this market in the EU could increase the total greatly in 2021, based on an analysis of anticipated marketing authorization application submissions and approval decisions.

The coming year could feature first-time approvals in the EU for at least five gene therapies, and regulatory submissions for...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Cell & Gene Therapies

More from Advanced Technologies